Pub Date : 2024-08-22DOI: 10.1016/j.maturitas.2024.108094
Dan Wu, Eneyi E Kpokiri, Luthfi Azizatunnisa', Sara Rotenberg, Hannah Kuper, Joseph D Tucker
{"title":"Equitable cervical cancer screening for women with disabilities.","authors":"Dan Wu, Eneyi E Kpokiri, Luthfi Azizatunnisa', Sara Rotenberg, Hannah Kuper, Joseph D Tucker","doi":"10.1016/j.maturitas.2024.108094","DOIUrl":"https://doi.org/10.1016/j.maturitas.2024.108094","url":null,"abstract":"","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":" ","pages":"108094"},"PeriodicalIF":0.0,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2024-05-11DOI: 10.1016/j.maturitas.2024.108025
Dimitrios G Goulis
{"title":"\"We're only as needy as our unmet needs\".","authors":"Dimitrios G Goulis","doi":"10.1016/j.maturitas.2024.108025","DOIUrl":"10.1016/j.maturitas.2024.108025","url":null,"abstract":"","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":" ","pages":"108025"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.1016/j.maturitas.2023.04.164
Salma Bouguerra, Syrine Ben Saidane, Badreddine Bouguerra
{"title":"Management of ovarian cysts in postmenopausal women","authors":"Salma Bouguerra, Syrine Ben Saidane, Badreddine Bouguerra","doi":"10.1016/j.maturitas.2023.04.164","DOIUrl":"https://doi.org/10.1016/j.maturitas.2023.04.164","url":null,"abstract":"","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135154710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.1016/j.maturitas.2023.04.163
Tommaso Simoncini, Nils Schoof, Siir Su Saydam, Cecilia Caetano, Cecile Janssenswillen, Megan Scott, Mia Harvey, Carsten Moeller, Katrin Schaudig, Victoria Banks
Background: Women receiving endocrine adjuvant (EA) therapy after breast cancer treatment report high rates of menopausal symptoms including vasomotor symptoms (VMS). VMS impact quality of life and can lead to treatment discontinuation and reduced survival, but existing literature evaluating symptom burden and impact is limited. The REAL-world evIdence on vasomotor and other Symptoms in menopausal womEn (REALISE) study aimed to evaluate physician and patient perceptions of symptom burden and impact in women experiencing VMS while receiving EA therapy for breast cancer.
{"title":"Menopausal symptom burden and quality of life in women with breast cancer on endocrine adjuvant therapy: findings from the REALISE study","authors":"Tommaso Simoncini, Nils Schoof, Siir Su Saydam, Cecilia Caetano, Cecile Janssenswillen, Megan Scott, Mia Harvey, Carsten Moeller, Katrin Schaudig, Victoria Banks","doi":"10.1016/j.maturitas.2023.04.163","DOIUrl":"https://doi.org/10.1016/j.maturitas.2023.04.163","url":null,"abstract":"Background: Women receiving endocrine adjuvant (EA) therapy after breast cancer treatment report high rates of menopausal symptoms including vasomotor symptoms (VMS). VMS impact quality of life and can lead to treatment discontinuation and reduced survival, but existing literature evaluating symptom burden and impact is limited. The REAL-world evIdence on vasomotor and other Symptoms in menopausal womEn (REALISE) study aimed to evaluate physician and patient perceptions of symptom burden and impact in women experiencing VMS while receiving EA therapy for breast cancer.","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135154695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.1016/j.maturitas.2023.04.243
Elisabet Robert Marchal, Beatriz Roca Comella, Sandra Rodriguez Veret, Laia Sánchez Paniagua, Maria Jose Gamundi Rodriguez
Fragile X Syndrome is a confirmed cause of Primary Ovarian Insufficiency (POI). The frequency of women who carry a premutation is 1/300. This has many consequences with the most significant being the loss of reproductive hormones and infertility. However, there are 5-10% of spontaneous pregnancies. For this reason patients must be informed by genetic counselling of the risk of having a newborn who may carry a premutation or Fragile X Syndrome. We report the case of 33-year-old woman referred for 5-month-long amenorrhea. In the study, serum gonadotropins were found at menopausal range. The patient became pregnant without medical intervention and before having the results of the genetic study, which was diagnostic of carrier of Fragile X Syndrome premutation with 90 expanded CGG repeats. An amniocentesis was performed afterwards, which reported the 46XX newborn to be positive for complete mutation of Fragile X Syndrome, with 200 expanded CGG repeats. Finally, a girl with correct weight was born by vaginal delivery at 37.5 weeks. She presented late and slow psychomotor development in the first years of life and is currently receiving paediatric neurology follow-up.
{"title":"Would be mandatory Fragile X syndrome screening in Premature Ovarian Insufficiency study?","authors":"Elisabet Robert Marchal, Beatriz Roca Comella, Sandra Rodriguez Veret, Laia Sánchez Paniagua, Maria Jose Gamundi Rodriguez","doi":"10.1016/j.maturitas.2023.04.243","DOIUrl":"https://doi.org/10.1016/j.maturitas.2023.04.243","url":null,"abstract":"Fragile X Syndrome is a confirmed cause of Primary Ovarian Insufficiency (POI). The frequency of women who carry a premutation is 1/300. This has many consequences with the most significant being the loss of reproductive hormones and infertility. However, there are 5-10% of spontaneous pregnancies. For this reason patients must be informed by genetic counselling of the risk of having a newborn who may carry a premutation or Fragile X Syndrome. We report the case of 33-year-old woman referred for 5-month-long amenorrhea. In the study, serum gonadotropins were found at menopausal range. The patient became pregnant without medical intervention and before having the results of the genetic study, which was diagnostic of carrier of Fragile X Syndrome premutation with 90 expanded CGG repeats. An amniocentesis was performed afterwards, which reported the 46XX newborn to be positive for complete mutation of Fragile X Syndrome, with 200 expanded CGG repeats. Finally, a girl with correct weight was born by vaginal delivery at 37.5 weeks. She presented late and slow psychomotor development in the first years of life and is currently receiving paediatric neurology follow-up.","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135154708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.1016/j.maturitas.2023.04.158
Jean Jasmin Lee, Farah Safdar, Seng Bin Ang
Introduction & Rationale: This case highlights the multidisciplinary approach used in the management of sexual dysfunction in post-menopausal women. A 52-year-old Chinese female presented with an 8-month history of worsening dyspareunia, low libido and secondary anorgasmia. She was on continuous menopause hormone therapy (MHT) that was initiated 2 years prior. Her initial presenting complaints were hot flushes, sleep disruption, vaginal dryness and mood instability – all of which resolved with MHT. She was found to have secondary vaginismus contributed by stressors that perpetuated the sexual dysfunction cycle. Predisposing factors included mild stress incontinence since the birth of her second child 18 years ago and work-related stress. Psycho-social factors included anxiety about not being able to satisfy her husband’s sexual needs leading to his infidelity, and the impact on her marriage.
{"title":"A case report - Multidisciplinary approach to sexual dysfunction in post-menopausal women in Singapore","authors":"Jean Jasmin Lee, Farah Safdar, Seng Bin Ang","doi":"10.1016/j.maturitas.2023.04.158","DOIUrl":"https://doi.org/10.1016/j.maturitas.2023.04.158","url":null,"abstract":"Introduction & Rationale: This case highlights the multidisciplinary approach used in the management of sexual dysfunction in post-menopausal women. A 52-year-old Chinese female presented with an 8-month history of worsening dyspareunia, low libido and secondary anorgasmia. She was on continuous menopause hormone therapy (MHT) that was initiated 2 years prior. Her initial presenting complaints were hot flushes, sleep disruption, vaginal dryness and mood instability – all of which resolved with MHT. She was found to have secondary vaginismus contributed by stressors that perpetuated the sexual dysfunction cycle. Predisposing factors included mild stress incontinence since the birth of her second child 18 years ago and work-related stress. Psycho-social factors included anxiety about not being able to satisfy her husband’s sexual needs leading to his infidelity, and the impact on her marriage.","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135154488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.1016/j.maturitas.2023.04.172
Vittoria Frisetti Carpani, Giulia Misasi, Maria Magdalena Montt Guevara, Cristina Zito, Eleonora Russo, Tommaso Simoncini
{"title":"Vaginal Erbium Laser as a non-hormonal therapeutical procedure for managing urinary symptoms in breast and gynecological cancer survivors","authors":"Vittoria Frisetti Carpani, Giulia Misasi, Maria Magdalena Montt Guevara, Cristina Zito, Eleonora Russo, Tommaso Simoncini","doi":"10.1016/j.maturitas.2023.04.172","DOIUrl":"https://doi.org/10.1016/j.maturitas.2023.04.172","url":null,"abstract":"","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":"90 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135154709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Early menopause and premature ovarian insufficiency may increase the risk of sarcopenia: a systematic review and meta-analysis","authors":"Efstathios Divaris, Panagiotis Anagnostis, Nifon Gkekas, Evangelia Kouidi, Dimitrios Goulis","doi":"10.1016/j.maturitas.2023.04.075","DOIUrl":"https://doi.org/10.1016/j.maturitas.2023.04.075","url":null,"abstract":"","PeriodicalId":94131,"journal":{"name":"Maturitas","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135154694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：